ALNYLAM PHARMACEUTICALS, INC. (ALNY) Corporate Subsidiaries
ALNYLAM PHARMACEUTICALS, INC. (ALNY) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALNY
CIK: 1178670
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJohn Charters Jr
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-02 | PRIMARY DOCUMENT | 0001178670-26-000068 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001959173-26-007216 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-19 | PRIMARY DOCUMENT | 0001178670-26-000065 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001178670-26-000062 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001178670-26-000060 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | PRIMARY DOCUMENT | 0001178670-26-000048 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | PRIMARY DOCUMENT | 0001178670-26-000047 | View SEC Doc Filr Page |
| 3 | 2026-06-03 | 2026-06-01 | PRIMARY DOCUMENT | 0001178670-26-000046 | View SEC Doc Filr Page |
| 144 | 2026-06-01 | — | 144 Filing | 0001969223-26-000618 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-20 | 8-K | 0001628280-26-038499 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000042 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000041 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000040 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000039 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000038 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-05-22 | 2026-05-20 | PRIMARY DOCUMENT | 0001178670-26-000034 | View SEC Doc Filr Page |
| 4 | 2026-05-14 | 2026-05-13 | PRIMARY DOCUMENT | 0001178670-26-000017 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001422849-26-000061 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001422848-26-000050 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001107 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001628280-26-028605 | View SEC Doc Filr Page |
| 8-K | 2026-04-30 | 2026-04-30 | 8-K | 0001628280-26-028601 | View SEC Doc Filr Page |